COMMUNIQUÉS West-GlobeNewswire
![GlobalNewswire](/sites/santelog.com/www.santelog.com/themes/santelog/images/nasdacinner.png)
-
Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act
15/10/2018 - 07:01 -
Telix and ANMI Expand PSMA Imaging Partnership
15/10/2018 - 00:00 -
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
15/10/2018 - 00:00 -
Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Michael
12/10/2018 - 22:05 -
Terra Tech Corp. Announces Plans to Expand its Cannabis Dispensary Footprint with Purchase of Las Vegas Property
12/10/2018 - 22:05 -
Trevena to Present Phase 3, Open-Label Safety Study of Oliceridine at the American Society of Anesthesiologists Annual Meeting
12/10/2018 - 22:01 -
A Letter from Emblem’s President & CEO
12/10/2018 - 19:51 -
Michael DePerro, MD, Offers Minimally Invasive Gynecomastia Surgery Technique
12/10/2018 - 19:29 -
NovuHealth Named No. 5 on Minneapolis/St. Paul Business Journal's Fast 50 List for Two Years Running
12/10/2018 - 19:00 -
Innovation Pharmaceuticals Brilacidin as a Novel Inhibitor of Phosphodiesterase 4 (PDE4) Supports its Potential to Treat Autoimmune and Inflammatory Diseases; Company Invited to Present at Upcoming Crohn’s & Colitis Foundation Conference
12/10/2018 - 18:00 -
RAMSAY GENERALE DE SANTE : supplement to the offer document in respect of the public offer to the shareholders of Capio
12/10/2018 - 17:47 -
RAMSAY GENERALE DE SANTE : complément au document d'offre relatif à l'offre publique d'achat faite aux actionnaires de Capio
12/10/2018 - 17:47 -
Trident Brands Inc. Entering US Hemp CBD Market with Brain Armor® R3 Supplement
12/10/2018 - 17:34 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2018
12/10/2018 - 17:25 -
US Patent Trial & Appeal Board (PTAB) Upholds Silence Patent by Denying First of Five Patent Grant Review Applications Filed by Alnylam
12/10/2018 - 16:07 -
Silence Therapeutics Announces Receipt of a New European Notice of Intention to Grant a Patent and the Launch of an Interim European Injunction Application against Onpattro™
12/10/2018 - 16:05 -
Exagen Announces Launch of Novel Biomarker PC4d Associated with Thrombosis in Lupus
12/10/2018 - 16:01 -
Radius Health to Announce Third Quarter 2018 Financial Results, Host Conference Call and Live Webcast on November 1, 2018
12/10/2018 - 15:00 -
MPX Expands Maryland Footprint With Opening of Baltimore Dispensary
12/10/2018 - 14:30
Pages